Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Antimicrob Agents Chemother
1 Antiviral Res
1 Biochem Biophys Res Commun
2 J Virol Methods
1 Pediatrics
4 PLoS One
1 Vaccine
2 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antimicrob Agents Chemother

  1. GAILLARD V, Galloux M, Garcin D, Eleouet JF, et al
    A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

    Antiviral Res

  2. TILMANIS D, van Baalen C, Oh DY, Rossignol JF, et al
    The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
    Antiviral Res. 2017 Oct 3. pii: S0166-3542(17)30546.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  3. CHO J, Yi H, Jang EY, Lee MS, et al
    Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Biochem Biophys Res Commun. 2017 Oct 7. pii: S0006-291X(17)32007.
    PubMed     Text format     Abstract available

    J Virol Methods

  4. DUH D, Blazic B
    Single mutation in the matrix gene of seasonal influenza A viruses critically affects the performance of diagnostic molecular assay.
    J Virol Methods. 2017 Oct 6. pii: S0166-0934(17)30441.
    PubMed     Text format     Abstract available

  5. BARBIERI A, Panigada M, Soprana E, Di Mario G, et al
    Strategies to obtain multiple recombinant modified vaccinia Ankara vectors. Applications to influenza vaccines.
    J Virol Methods. 2017;251:7-14.
    PubMed     Text format     Abstract available


  6. ROBISON SG, Dunn AG, Richards DL, Leman RF, et al
    Changes in Influenza Vaccination Rates After Withdrawal of Live Vaccine.
    Pediatrics. 2017 Oct 6. pii: e20170516. doi: 10.1542/peds.2017-0516.
    PubMed     Text format     Abstract available

    PLoS One

  7. BARAUSKAS O, Xing W, Aguayo E, Willkom M, et al
    Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs.
    PLoS One. 2017;12:e0185998.
    PubMed     Text format     Abstract available

  8. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Text format     Abstract available

  9. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Text format     Abstract available

  10. VANLEUVEN JT, Ridenhour BJ, Gonzalez AJ, Miller CR, et al
    Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses.
    PLoS One. 2017;12:e0178408.
    PubMed     Text format     Abstract available


  11. OFORI-ANYINAM O, Leroux-Roels G, Drame M, Aerssens A, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults >/=50years of age: Results from a phase III, randomized, non-i
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31228.
    PubMed     Text format     Abstract available


  12. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
    Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Virology. 2017;511:142-151.
    PubMed     Text format     Abstract available

  13. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
    Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Virology. 2017;511:123-134.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.